Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold.
暂无分享,去创建一个
Hamidreza Ghandehari | Khaled Greish | A. Ray | H. Ghandehari | K. Greish | Tian Yu | Abhijit Ray | Tian Yu | Lawrence D McGill | L. McGill
[1] Zongxi Li,et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.
[2] Yasuo Yoshioka,et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. , 2011, Nature nanotechnology.
[3] Jiao Sun,et al. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. , 2010, Biomaterials.
[4] M Geso,et al. Gold nanoparticles: a new X-ray contrast agent. , 2007, The British journal of radiology.
[5] C. Haynes,et al. Stability of small mesoporous silica nanoparticles in biological media. , 2011, Chemical communications.
[6] Jianlin Shi,et al. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility , 2011 .
[7] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles for intracellular controlled drug delivery. , 2010, Small.
[8] Linlin Li,et al. Facile and Scalable Synthesis of Tailored Silica “Nanorattle” Structures , 2009 .
[9] J. Pounds,et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[10] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[11] Victor S-Y Lin,et al. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. , 2011, ACS nano.
[12] Yaping Li,et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.
[13] Victor S-Y Lin,et al. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. , 2006, Journal of the American Chemical Society.
[14] Steven J. Shire,et al. Viscosity Analysis of High Concentration Bovine Serum Albumin Aqueous Solutions , 2011, Pharmaceutical Research.
[15] Dong Chen,et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. , 2010, ACS nano.
[16] Ernesto L. Schiffrin,et al. Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.
[17] Jeffrey I. Zink,et al. Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. , 2010, Environmental science & technology.
[18] Peter Wick,et al. Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.
[19] Hamidreza Ghandehari,et al. Cellular uptake and cytotoxicity of silica nanotubes. , 2008, Nano letters.
[20] Feng Zhao,et al. Acute toxicological effects of copper nanoparticles in vivo. , 2006, Toxicology letters.
[21] V. Postnov,et al. Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicity , 2010, International journal of nanomedicine.
[22] Yasuo Tsutsumi,et al. Silica nanoparticles as hepatotoxicants. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[24] Hamidreza Ghandehari,et al. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. , 2011, ACS nano.
[25] Xinglu Huang,et al. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. , 2011, Biomaterials.
[26] Yu Tian,et al. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice , 2011, Nanotechnology.
[27] E. Schiffrin,et al. Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.
[28] Robert Langer,et al. The biocompatibility of mesoporous silicates. , 2008, Biomaterials.
[29] Y. Tsutsumi,et al. Effect of surface charge on nano-sized silica particles-induced liver injury. , 2011, Die Pharmazie.
[30] Liyi Shi,et al. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice , 2010, Archives of Toxicology.
[31] Guping Tang,et al. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection , 2009, Journal of applied toxicology : JAT.
[32] V. Muzykantov. Biomedical aspects of targeted delivery of drugs to pulmonary endothelium , 2005, Expert opinion on drug delivery.
[33] Conrad Coester,et al. Particle and Fibre Toxicology BioMed Central Methodology , 2008 .
[34] Chen Chang,et al. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. , 2008, Small.
[35] G. Oberdörster,et al. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.